R. Pyrrolidine dithiocarbamate restores endothelial cell membrane integrity and attenuates monocrotaline-induced pulmonary artery hypertension. Am J Physiol Lung Cell Mol Physiol 294: L1250-L1259, 2008. First published April 4, 2008 doi:10.1152/ajplung.00069.2007.-Monocrotaline (MCT)-induced pulmonary artery hypertension (PAH) in rats is preceded by an inflammatory response, progressive endothelial cell membrane disruption, reduction in the expression of caveolin-1, and reciprocal activation of STAT3 (PY-STAT3). Superoxide and NF-B have been implicated in PAH. To evaluate the role of caveolin-1, PY-STAT3 activation, and superoxide in PAH, MCT-injected rats were treated daily with pyrrolidine dithiocarbamate (PDTC; starting on days 1, 3, and 14 ϫ 2 wk), an inhibitor of inflammation and NF-B activation. Hemodynamic data, the expression of inhibitory (I)-B␣, caveolin-1, and Tie2 (a membrane protein), activation of PY-STAT3 and NF-B, and superoxide chemiluminescence were examined. Rats developed progressive PAH at 2 wk post-MCT. There was progressive reduction in the expression of caveolin-1, Tie2, and activation of PY-STAT3 in the lungs. Reduction in I-B␣ expression was present at 2 and 4 wk post-MCT. Superoxide chemiluminescence and NF-B activation were observed only at 2 wk post-MCT and both decreased by 4 wk post-MCT despite progressive PAH. PDTC (starting on days 1 and 3) rescued caveolin-1 and Tie2, reversed MCT-induced PY-STAT3 activation, and attenuated PAH. In addition, PDTC restored I-B␣ expression and reduced superoxide chemiluminescence at 2 wk but did not inhibit NF-B activation despite attenuation of PAH. PDTC had no effect on established PAH. Increased superoxide chemiluminescence and NF-B activation appear to be a transient phenomenon in the MCT model. Thus the disruption of endothelial cell membrane integrity resulting in caveolin-1 loss and reciprocal activation of PY-STAT3 plays a key role in the MCT-induced PAH.caveolin-1; inhibitory B␣; inflammation; PY-STAT3; Tie2 DESPITE MAJOR ADVANCES MADE in the understanding of the pathogenesis of pulmonary artery hypertension (PAH), the precise molecular mechanism remains elusive. Both inflammation and oxidant stress have been implicated in the pathogenesis of PAH. Perivascular infiltration with inflammatory cells is evident in plexiform lesions in the lungs of patients with primary PAH, and the levels of proinflammatory cytokines such as IL-1 and IL-6 are elevated in the serum (22,47). In addition, the occurrence of PAH in patients suffering from systemic inflammatory diseases is not uncommon (14). Monocrotaline (MCT)-induced PAH in rats is preceded by an inflammatory response in the lungs and is associated with an early and progressive increase in the expression of IL-6 mRNA and IL-6 bioactivity in the lungs (6). IL-6 is known to activate STAT3, a transcription factor that positively regulates cell growth and proliferation. Tyrosine phosphorylation of STAT3 is required for STAT3 dimerization and subsequent translocation to nucleus where it binds with D...